GB202013383D0 - Process - Google Patents

Process

Info

Publication number
GB202013383D0
GB202013383D0 GBGB2013383.1A GB202013383A GB202013383D0 GB 202013383 D0 GB202013383 D0 GB 202013383D0 GB 202013383 A GB202013383 A GB 202013383A GB 202013383 D0 GB202013383 D0 GB 202013383D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2013383.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan SA
Original Assignee
Givaudan SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan SA filed Critical Givaudan SA
Priority to GBGB2013383.1A priority Critical patent/GB202013383D0/en
Publication of GB202013383D0 publication Critical patent/GB202013383D0/en
Priority to PCT/EP2021/073378 priority patent/WO2022043320A1/en
Priority to KR1020237009953A priority patent/KR20230058096A/ko
Priority to ES21769101T priority patent/ES2985349T3/es
Priority to CN202180052436.3A priority patent/CN116209659A/zh
Priority to CN202511947370.0A priority patent/CN121717789A/zh
Priority to MX2023002234A priority patent/MX2023002234A/es
Priority to BR112023002055A priority patent/BR112023002055A2/pt
Priority to JP2023513348A priority patent/JP7818578B2/ja
Priority to US18/021,620 priority patent/US20230312506A1/en
Priority to PL21769101.3T priority patent/PL4204407T3/pl
Priority to IL300613A priority patent/IL300613A/en
Priority to EP21769101.3A priority patent/EP4204407B1/en
Priority to CONC2023/0003013A priority patent/CO2023003013A2/es
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Seasonings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
GBGB2013383.1A 2020-08-26 2020-08-26 Process Ceased GB202013383D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB2013383.1A GB202013383D0 (en) 2020-08-26 2020-08-26 Process
EP21769101.3A EP4204407B1 (en) 2020-08-26 2021-08-24 Process
MX2023002234A MX2023002234A (es) 2020-08-26 2021-08-24 Proceso.
JP2023513348A JP7818578B2 (ja) 2020-08-26 2021-08-24 プロセス
ES21769101T ES2985349T3 (es) 2020-08-26 2021-08-24 Proceso
CN202180052436.3A CN116209659A (zh) 2020-08-26 2021-08-24 方法
CN202511947370.0A CN121717789A (zh) 2020-08-26 2021-08-24 由2-哌啶酸原位形成清凉剂的方法
PCT/EP2021/073378 WO2022043320A1 (en) 2020-08-26 2021-08-24 Process
BR112023002055A BR112023002055A2 (pt) 2020-08-26 2021-08-24 Processo
KR1020237009953A KR20230058096A (ko) 2020-08-26 2021-08-24 방법
US18/021,620 US20230312506A1 (en) 2020-08-26 2021-08-24 Process
PL21769101.3T PL4204407T3 (pl) 2020-08-26 2021-08-24 Proces
IL300613A IL300613A (en) 2020-08-26 2021-08-24 process
CONC2023/0003013A CO2023003013A2 (es) 2020-08-26 2023-03-13 Proceso

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2013383.1A GB202013383D0 (en) 2020-08-26 2020-08-26 Process

Publications (1)

Publication Number Publication Date
GB202013383D0 true GB202013383D0 (en) 2020-10-07

Family

ID=72660759

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2013383.1A Ceased GB202013383D0 (en) 2020-08-26 2020-08-26 Process

Country Status (13)

Country Link
US (1) US20230312506A1 (https=)
EP (1) EP4204407B1 (https=)
JP (1) JP7818578B2 (https=)
KR (1) KR20230058096A (https=)
CN (2) CN116209659A (https=)
BR (1) BR112023002055A2 (https=)
CO (1) CO2023003013A2 (https=)
ES (1) ES2985349T3 (https=)
GB (1) GB202013383D0 (https=)
IL (1) IL300613A (https=)
MX (1) MX2023002234A (https=)
PL (1) PL4204407T3 (https=)
WO (1) WO2022043320A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202105661D0 (en) * 2021-04-21 2021-06-02 Givaudan Sa Organic compounds
WO2022207944A2 (en) 2022-07-11 2022-10-06 Symrise Ag Novel mixtures and uses of (2e)-3-(1,3-benzodioxol-5-yl)-n-phenyl-n-(tetrahydro-3-furanyl)-2-propenamide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA987383B (en) * 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.
WO2006091731A2 (en) * 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
JP2009535327A (ja) * 2006-04-25 2009-10-01 ディシュマン・ファーマシューティカルズ・アンド・ケミカルズ・リミテッド ロピバカイン塩酸塩無水物およびその調製
EP2850072B1 (en) * 2012-04-25 2016-08-31 Theravance Biopharma R&D IP, LLC Hepatitis c virus inhibitors
TWI610916B (zh) * 2012-08-03 2018-01-11 廣東東陽光藥業有限公司 作爲丙型肝炎抑制劑的橋環化合物及其在藥物中的應用
EP3049435A4 (en) * 2013-09-27 2017-03-29 Merck Sharp & Dohme Corp. Factor xia inhibitors
WO2015054087A1 (en) * 2013-10-07 2015-04-16 Merck Sharp & Dohme Corp. FACTOR XIa INHIBITORS
CN108129476A (zh) * 2017-11-27 2018-06-08 华中农业大学 一种杂环内酰胺衍生物及其用于作物病原菌杀菌剂的用途
EP4045491A1 (en) * 2019-10-17 2022-08-24 Givaudan SA Substituted azacyles as trmp8 modulators

Also Published As

Publication number Publication date
IL300613A (en) 2023-04-01
JP2023538761A (ja) 2023-09-11
US20230312506A1 (en) 2023-10-05
WO2022043320A1 (en) 2022-03-03
ES2985349T3 (es) 2024-11-05
BR112023002055A2 (pt) 2023-03-07
KR20230058096A (ko) 2023-05-02
JP7818578B2 (ja) 2026-02-20
CO2023003013A2 (es) 2023-04-17
EP4204407B1 (en) 2024-06-19
EP4204407A1 (en) 2023-07-05
PL4204407T3 (pl) 2024-11-04
CN116209659A (zh) 2023-06-02
CN121717789A (zh) 2026-03-24
MX2023002234A (es) 2023-03-15

Similar Documents

Publication Publication Date Title
GB202007980D0 (en) Process
GB202104958D0 (en) Process
GB202005217D0 (en) Process
GB202005468D0 (en) Enzyme-media process
GB202002417D0 (en) Process
GB202108985D0 (en) Process
GB202003906D0 (en) Process
GB202002416D0 (en) Process
PL4204407T3 (pl) Proces
GB202110568D0 (en) Process
GB202104681D0 (en) Process
GB202019576D0 (en) Process
GB202102673D0 (en) Process
GB202101796D0 (en) Process
GB202020054D0 (en) Process
GB202017456D0 (en) Process
GB202009069D0 (en) Process
GB202001226D0 (en) Process
GB202000901D0 (en) Process
GB202117726D0 (en) Process
GB202117617D0 (en) Process
GB202117202D0 (en) Process
GB202116895D0 (en) Process
GB202116403D0 (en) Process
GB202112262D0 (en) Process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)